Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ended the attempted buyout of the company by Alcon. Alcon announced its ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company ...

Five diagnostic tools are critical to assist surgeons in choosing the most appropriate IOL for the patient and maintaining ...

Using neutral language with patients and thorough documentation can help mitigate your practice’s legal risks when utilizing ...

Shareholders of Staar Surgical, a manufacturer of the Implantable Collamer Lens, have likely definitively voted against Alcon’s $1.6 billion buyout offer. Broadwood Partners, which holds 30.2% of ...

LAKE FOREST, Calif. - STAAR Surgical Company (NASDAQ:STAA) announced Tuesday it intends to terminate its merger agreement with Alcon after failing to secure the necessary stockholder approval at a ...

Shareholders of Staar Surgical rejected a proposal to sell the company to Alcon for about $1.6 billion, a win for activist investors who had campaigned to block the deal Staar, a maker of implantable ...

Scientists have unveiled a new way to capture ultra-sharp optical images without lenses or painstaking alignment. The approach uses multiple sensors to collect raw light patterns independently, then ...

Since launching in 2022, the partnership’s dry eye mitigation, measurement, and management initiatives have drawn broad ...

(Bloomberg) -- SpyGlass Pharma Inc. filed for an initial public offering to help fund late-stage trials of its intraocular lens and drug delivery solutions to treat patients with chronic eye ...